Persistent parkinsonism and tardive dyskinesia induced by clebopride
1993; Wiley; Volume: 8; Issue: 2 Linguagem: Inglês
10.1002/mds.870080235
ISSN1531-8257
AutoresFélix Javier Jiménez‐Jiménez, Francisco Cabrera‐Valdivia, Lucía Ayuso‐Peralta, J. Cameselle Tejeiro, Antonio Vaquero, E García-Albea,
Tópico(s)Alzheimer's disease research and treatments
ResumoMovement DisordersVolume 8, Issue 2 p. 246-247 Communication Persistent parkinsonism and tardive dyskinesia induced by clebopride Félix Javier Jiménez-Jiménez, Félix Javier Jiménez-Jiménez Department of Neurology, Hospital Universitario “Príncipe de Asturias”, Alcalá de Henares, Madrid, SpainSearch for more papers by this authorFrancisco Cabrera-Valdivia, Francisco Cabrera-Valdivia Department of Neurology, Hospital Universitario “Príncipe de Asturias”, Alcalá de Henares, Madrid, SpainSearch for more papers by this authorLucía Ayuso-Peralta, Lucía Ayuso-Peralta Department of Neurology, Hospital Universitario “Príncipe de Asturias”, Alcalá de Henares, Madrid, SpainSearch for more papers by this authorJoséa Tejeiro, Joséa Tejeiro Department of Neurology, Hospital Universitario “Príncipe de Asturias”, Alcalá de Henares, Madrid, SpainSearch for more papers by this authorAntonio Vaquero, Antonio Vaquero Department of Neurology, Hospital Universitario “Príncipe de Asturias”, Alcalá de Henares, Madrid, SpainSearch for more papers by this authorEsteban García-Albea, Esteban García-Albea Department of Neurology, Hospital Universitario “Príncipe de Asturias”, Alcalá de Henares, Madrid, SpainSearch for more papers by this author Félix Javier Jiménez-Jiménez, Félix Javier Jiménez-Jiménez Department of Neurology, Hospital Universitario “Príncipe de Asturias”, Alcalá de Henares, Madrid, SpainSearch for more papers by this authorFrancisco Cabrera-Valdivia, Francisco Cabrera-Valdivia Department of Neurology, Hospital Universitario “Príncipe de Asturias”, Alcalá de Henares, Madrid, SpainSearch for more papers by this authorLucía Ayuso-Peralta, Lucía Ayuso-Peralta Department of Neurology, Hospital Universitario “Príncipe de Asturias”, Alcalá de Henares, Madrid, SpainSearch for more papers by this authorJoséa Tejeiro, Joséa Tejeiro Department of Neurology, Hospital Universitario “Príncipe de Asturias”, Alcalá de Henares, Madrid, SpainSearch for more papers by this authorAntonio Vaquero, Antonio Vaquero Department of Neurology, Hospital Universitario “Príncipe de Asturias”, Alcalá de Henares, Madrid, SpainSearch for more papers by this authorEsteban García-Albea, Esteban García-Albea Department of Neurology, Hospital Universitario “Príncipe de Asturias”, Alcalá de Henares, Madrid, SpainSearch for more papers by this author First published: 1993 https://doi.org/10.1002/mds.870080235Citations: 14AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1 Montagna P, Gabellini AS, Monari L, Lugaresi E. Parkinsonian syndrome after long-term treatment with clebopride. Mov Disord 1992; 7: 89– 90. 2 Stephen PJ, Williamson J. Drug-induced parkinsonism in the elderly. Lancet 1984; 2: 1082– 1083. 3 Hardie RJ, Lees AJ. Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa. J Neurol Neurosurg Psychiatry 1988; 51: 850– 854. 4 Jankovic J. Drug-induced movement disorders. In: Movement disorders. Course 143 of the 43rd Annual Meeting of the American Academy of Neurology, Boston, April 21, 1991: 105– 124. 5 Melamed E, Achiron A, Shapira A, Davidovicz S. Persistent and progressive parkinsonism after discontinuation of chronic neuroleptic therapy: an additional tardive syndrome? Clin Neuropharmacol 1991; 14: 273– 278. 6 Benvenuti F, Baroni A, Bandinelli S, Ferrucci L, Corradetti R, Pantaleo T. Flunarizine-induced parkinsonism in the elderly. J Clin Pharmacol 1988; 28: 600– 608. 7 García-Ruiz PJ, De Yébenes JG, Jiménez-Jiménez FJ, Vázquez A, Urra DG, Morales B. Parkinsonism associated with calcium channel blockers: a prospective follow-up study. Clin Neuropharmacol 1992; 15: 19– 26. 8 López-Alemany M. Parkinsonism as late toxic effect of dihydropyridines. Lancet 1986; 2: 737. 9 López Rois F, Conce Pico M, Calvo Fernández J, Novo I, Castro Gago M. Síndrome extrapiramidal medicamentoso. A propósito de 22 observaciones. An Esp Pediatr 1987; 26: 91– 93. Citing Literature Volume8, Issue21993Pages 246-247 ReferencesRelatedInformation
Referência(s)